Vitamin Blue Revenue vs. Total Asset

VTMB -  USA Stock  

USD 0.0001  0.00  0.00%

For Vitamin Blue profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vitamin Blue to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vitamin Blue utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vitamin Blue's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vitamin Blue over time as well as its relative position and ranking within its peers. Also, please take a look at World Market Map.

Vitamin Current Profitability Trends 

 
Refresh
Is Vitamin Blue's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vitamin Blue. If investors know Vitamin will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vitamin Blue listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Vitamin Blue is measured differently than its book value, which is the value of Vitamin that is recorded on the company's balance sheet. Investors also form their own opinion of Vitamin Blue's value that differs from its market value or its book value, called intrinsic value, which is Vitamin Blue's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vitamin Blue's market value can be influenced by many factors that don't directly affect Vitamin Blue's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vitamin Blue's value and its price as these two are different measures arrived at by different means. Investors typically determine Vitamin Blue value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vitamin Blue's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Vitamin Blue Total Asset vs. Revenue Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Vitamin Blue's current stock value. Our valuation model uses many indicators to compare Vitamin Blue value to that of its competitors to determine the firm's financial worth.
Vitamin Blue is rated third in revenue category among related companies. It is rated third in total asset category among related companies fabricating about  0.24  of Total Asset per Revenue. The ratio of Revenue to Total Asset for Vitamin Blue is roughly  4.18 . Comparative valuation analysis is a catch-all model that can be used if you cannot value Vitamin Blue by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Vitamin Blue's OTC Stock . Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vitamin Blue's earnings, one of the primary drivers of an investment's value.

Vitamin Revenue vs. Competition

Vitamin Blue is rated third in revenue category among related companies. Market size based on revenue of Leisure industry is at this time estimated at about 219.34 Billion. Vitamin Blue adds roughly 146,210 in revenue claiming only tiny portion of all equities under Leisure industry.

Vitamin Total Asset vs. Revenue

Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Vitamin Blue 
Revenue 
 = 
Money Received 
Discounts and Returns 
146.21 K
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include product or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.
Vitamin Blue 
Total Asset 
 = 
Tangible Assets 
Intangible Assets 
35 K
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.

Vitamin Total Asset Comparison

Vitamin Blue is currently under evaluation in total asset category among related companies.

Vitamin Blue Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Vitamin Blue, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vitamin Blue will eventually generate negative long term returns. The profitability progress is the general direction of Vitamin Blue's change in net profit over the period of time. It can combine multiple indicators of Vitamin Blue, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Vitamin Blue, Inc. designs, develops, produces, and distributes water boardsports apparel and related products primarily in the United States. Vitamin Blue, Inc. was founded in 1999 and is based in Costa Mesa, California. Vitamin Blue operates under Leisure classification in the United States and is traded on OTC Exchange. It employs 1 people.

Vitamin Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Vitamin Blue. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vitamin Blue position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vitamin Blue's important profitability drivers and their relationship over time.

Use Vitamin Blue in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vitamin Blue position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vitamin Blue will appreciate offsetting losses from the drop in the long position's value.

Vitamin Blue Pair Trading

Vitamin Blue Pair Trading Analysis

Correlation analysis and pair trading evaluation for Vitamin Blue and Oriental Land. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  

Use Investing Themes to Complement your Vitamin Blue position

In addition to having Vitamin Blue in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Cars Thematic Idea Now

Cars
Cars Theme
Domestic and international companies involved in manufacturing and serving automobiles and trucks. Cars theme has 30 constituents.
View All  Next Launch Cars
Also, please take a look at World Market Map. Note that the Vitamin Blue information on this page should be used as a complementary analysis to other Vitamin Blue's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Optimization module to compute new portfolio that will generate highest expected return given your specified tolerance for risk.

Complementary Tools for Vitamin OTC Stock analysis

When running Vitamin Blue price analysis, check to measure Vitamin Blue's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vitamin Blue is operating at the current time. Most of Vitamin Blue's value examination focuses on studying past and present price action to predict the probability of Vitamin Blue's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vitamin Blue's price. Additionally, you may evaluate how the addition of Vitamin Blue to your portfolios can decrease your overall portfolio volatility.
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Go
Global Correlations
Find global opportunities by holding instruments from different markets
Go
Portfolio Anywhere
Track or share privately all of your investments from the convenience of any device
Go
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Go
Competition Analyzer
Analyze and compare many basic indicators for a group of related or unrelated entities
Go
CEO Directory
Screen CEOs from public companies around the world
Go
Watchlist Optimization
Optimize watchlists to build efficient portfolio or rebalance existing positions based on mean-variance optimization algorithm
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Equity Search
Search for activelly traded equities including funds and ETFs from over 30 global markets
Go
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance
Go
To fully project Vitamin Blue's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Vitamin Blue at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Vitamin Blue's income statement, its balance sheet, and the statement of cash flows.
Potential Vitamin Blue investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Vitamin Blue investors may work on each financial statement separately, they are all related. The changes in Vitamin Blue's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Vitamin Blue's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.